Revolution Medicines, Inc.RVMDNASDAQ

Revenue (LTM)

Net Income (LTM)

$-1.1B

-88.5% YoY

Free Cash Flow

$-914M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.9B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	29	35↑20.4%	12↓67.3%	0	0
Gross Profit	29	35↑20.4%	12↓67.3%	0	-17
Operating Income	-188	-258↓37.4%	-487↓88.6%	-690↓41.5%	-1,182↓71.5%
Net Income	-187	-249↓32.9%	-436↓75.5%	-600↓37.5%	-1,131↓88.5%
EBITDA	-180	-249↓38.3%	-478↓92.2%	-678↓41.8%	-1,091↓60.9%
EPS Diluted	-2.47	-3.08↓24.7%	-3.86↓25.3%	-3.58↑7.3%	-5.95↓66.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	108	161↑48.8%	696↑331.3%	543↓22.0%	384↓29.3%
Total Current Assets	590	660↑11.9%	1,879↑184.7%	2,328↑23.9%	2,075↓10.9%
Total Assets	738	812↑10.0%	2,062↑153.9%	2,558↑24.1%	2,355↓8.0%
Total Current Liabilities	60	62↑2.7%	144↑132.1%	164↑13.9%	290↑77.2%
Total Liabilities	135	127↓6.4%	236↑85.8%	293↑24.5%	723↑146.7%
Total Equity	603	685↑13.7%	1,826↑166.5%	2,265↑24.0%	1,631↓28.0%
Total Debt	67	64↓3.6%	88↑37.0%	136↑54.5%	159↑16.8%
Net Debt	-42	-97↓132.2%	-608↓525.7%	-407↑33.0%	-225↑44.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-147	-224↓52.5%	-351↓56.2%	-557↓59.0%	-898↓61.0%
Capital Expenditure	-7	-11↓65.7%	-8↑28.5%	-10↓33.4%	-16↓55.1%
Free Cash Flow	-154	-235↓53.0%	-358↓52.3%	-568↓58.5%	-914↓60.9%
Stock-Based Comp	21	31↑50.5%	62↑98.0%	79↑28.2%	118↑49.5%
Net Change in Cash	5	53↑983.9%	535↑910.6%	-153↓128.6%	-158↓3.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance